Telesis Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1.75	30.59	82.81	13.46	29.14
Short-Term Investments	17.59	13.16	0	0	0
Cash & Cash Equivalents	19.33	43.75	82.81	13.46	29.14
Cash Growth	-55.81%	-47.16%	515.06%	-53.81%	-
Receivables	5.99	5.85	3.67	2.27	1.49
Inventory	4.03	2.2	2.37	0.6	0.71
Other Current Assets	1.01	3.29	4.35	0.85	0.09
Total Current Assets	30.35	55.09	93.18	17.18	31.43
Property, Plant & Equipment	34.52	8.52	5.74	3.78	0.89
Long-Term Investments	0	0	0	0	0.08
Goodwill and Intangibles	4.86	16.77	16.73	5.82	6.36
Other Long-Term Assets	0.68	0.98	0.61	0.08	0
Total Long-Term Assets	40.06	26.27	23.07	9.68	7.33
Total Assets	70.41	81.36	116.26	26.86	38.76
Accounts Payable	3.28	1.3	2.5	1.19	0.61
Deferred Revenue	0.43	4.1	0.36	0.65	0.15
Current Debt	1.82	0.64	1.84	2.12	0.11
Other Current Liabilities	2.65	7.47	5.04	1.67	0.85
Total Current Liabilities	8.18	13.5	9.73	5.63	1.72
Long-Term Debt	32.56	20.79	15.48	6.21	4.66
Other Long-Term Liabilities	0.13	0.51	0.26	1.57	0.97
Total Long-Term Liabilities	32.69	21.3	15.74	7.78	5.63
Total Liabilities	40.87	34.8	25.47	13.41	7.35
Total Debt	34.38	21.43	17.32	8.33	4.77
Debt Growth	60.45%	23.70%	108.05%	74.62%	-
Retained Earnings	-161.47	-113.74	-65.27	-26.31	-8.3
Comprehensive Income	0	-0	0	0	0
Shareholders' Equity	0.24	46.57	90.78	-25.46	-7.5
Net Cash / Debt	-15.05	22.33	65.48	5.14	24.38
Net Cash / Debt Growth	-	-65.91%	1174.75%	-78.93%	-
Net Cash Per Share	-0.50	0.76	3.59	1.03	1.63
Working Capital	22.17	41.59	83.45	11.56	29.71
Book Value Per Share	0.01	1.58	4.98	-5.09	-0.50

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).